Atlas Trials

Evaluate Safety and Immunogenicity of a Booster Dose of Pneumococcal Conjugate Vaccine in Preterm Born Infants.

Clinical trial NCT00609492 · COMPLETED

Trial details

NCT number
NCT00609492
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Infections, StreptococcalStreptococcus Pneumoniae Vaccines
Start date
2008-01-03
Primary completion
2008-11-10
Enrollment
245

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.